Who Owned Georgia English.pdf
Who Owned Georgia English.pdf Who Owned Georgia English.pdf
People’s Pharmacy, a small pharmaceutical chain, complains thatit is impossible to stock as much as he needs without having todeal with the three importers. 230 With the three major companiescontrolling most of the imported medical products, many suspectthey have collaborated to fixed the prices.Studio Monitor mentions this in an investigative report onGeorgia’s pharmaceutical companies. “The three main players(PSP, Aversi, GPC) on the Georgian pharmaceutical market havean agreement between each other to cooperate with differentsuppliers. If one of them works with Richter, the other two donot meddle. If you tell Richter you’re a new organization andyou want to cooperate with them, they tell you, “I already have apartner in Georgia and don’t need another.” 231Kvaratskhelia explains, “It’s like this: one company importsdrugs X and another imports drugs Y and they share these drugstogether. They managed to create an oligopoly by sharing theimport between their companies and sell the shared importeddrugs to pharmacies at a fixed price. Being the major importersand having exclusive contracts with manufacturers, they acquireda position in which pharmacies have become dependent on theirsupply. No other importer is able to sign a contract with them(the manufacturers). Through this control of the import marketand the sharing of exclusive pharmaceuticals, every pharmacy isdependent on them, if it wants to sell foreign drugs.” 232230 Interview Valeri Kvaratskhelia General Director People’s Pharmacy, andrespondent who prefers to stay anonymous. Report on PharmaceuticalMarket in Georgia. Pages 14-15 Transparency International Georgiahttp://transparency.ge/sites/default/files/post_attachments/The%20Pharmaceutical%20Market%20in%20Georgia_June%202012l_0.pdf Accessed05/12/2012231 Darkside of the Georgian Pharmacy. Studio Monitor report. 2009 http://ick.ge/ka/jinvestigation/322-2010-02-17-09-21-51.html Accessed 05/12/2012232 Interview Valeri Kvaratskhelia General Director People’s Pharmacy, andrespondent who prefers to stay anonymous. Report on Pharmaceutical Marketin Georgia. Transparency International Georgia http://transparency.ge/sites/default/files/post_attachments/The%20Pharmaceutical%20Market%20in%20Georgia_June%202012l_0.pdf Accessed 05/12/201256
Another pharmaceutical professional, speaking to TI Georgiaon condition of anonymity, said that by selling these shareddrugs at prices 10% below the retail value, the companies areable to put smaller competitors out of business. 233 But GochaGogilashvili, General Director of PSP, stated that a fixed marginis normal market practice and is how a company makes a profiton its distribution of medicines they don’t sell in their ownpharmacies. 234 What isn’t normal, though, is that the largestimporter/distributor is also the largest retailer. There’s nothingtechnically wrong with being a distributor/retailer, it’s just thatin this case, the large companies use their dominant position as adistributor to strengthen their position on the retail level.In 2009, the government stepped in to adopt new amendmentsto increase market competition. Importers now have thepossibility to select the cheapest version of a certain medicine ina particular country and to look for new medicines that had notbeen allowed in Georgia or were very difficult to distribute onthe Georgian market. 235 Companies have more opportunities toimport a medical product through different channels. While thechanges were welcomed, they have little effect on the currentsituation, as the main players still dominate the market. 236Because they are the largest distributors on the market,Aversi, PSP and GPC benefit from the small, fragmented retailoutlet market that cannot afford to import their own medicines.Even the investment guide for the pharmaceutical market states233 Interview with respondent who refers to stay anonymous on 3 October. 2011Report on Pharmaceutical Market in Georgia. Transparency InternationalGeorgia http://transparency.ge/sites/default/files/post_attachments/The%20Pharmaceutical%20Market%20in%20Georgia_June%202012l_0.pdf Accessed05/12/2012234 Interview Gocha Gogilashvili, General Director PSP. Report onPharmaceutical Market in Georgia. Page 18Transparency InternationalGeorgia http://transparency.ge/sites/default/files/post_attachments/The%20Pharmaceutical%20Market%20in%20Georgia_June%202012l_0.pdf Accessed05/12/2012235 Ibid p. 15236 Ibid p. 2957
- Page 7 and 8: closely affiliated to Eduard Shevar
- Page 10 and 11: news to the Autonomous Republic of
- Page 12 and 13: If the authorities had wanted, they
- Page 14 and 15: Tbilisi Mayor Gigi Ugulava, who was
- Page 16 and 17: Kakhi Beqauri and Eldar Mdinaradze.
- Page 18 and 19: oadcasting 39 but sold the frequenc
- Page 20 and 21: He went on to say that later that d
- Page 22 and 23: with Russia, which sent the nation
- Page 24 and 25: Irakli Okruashvili case in Septembe
- Page 26 and 27: them in the street. They took trans
- Page 28 and 29: Maestro contends the dishes were pa
- Page 30 and 31: In the meantime, Chikovani has rema
- Page 32 and 33: General Media arrived in early 2011
- Page 34 and 35: merger of the Caucasus Network, Geo
- Page 36 and 37: In cases when the owner of a busine
- Page 38 and 39: the shares and LLC Investico Allian
- Page 40 and 41: 38WHO OWNED OUTDOOR ADVERTISING?Whe
- Page 42 and 43: The latest Civil registry entry has
- Page 44 and 45: On September 12, 2011, JSC Adprojec
- Page 46 and 47: ut we are only partly correct. The
- Page 48 and 49: estaurants to confiscate documents
- Page 50 and 51: Delta Holding, the football (soccer
- Page 52 and 53: A PHARMACEUTICAL OLIGOPOLY“Why ar
- Page 54 and 55: to construct manufacturing sites an
- Page 56 and 57: A loan from the European Bank for R
- Page 60 and 61: the large import/distributors and r
- Page 62 and 63: that the decrease could be their sh
- Page 64 and 65: Kvadimax, Enozid H, Musitroli, Amta
- Page 66 and 67: 64IT’S CALLED DEVELOPMENTIn 2002
- Page 68 and 69: uling party leader in the region wa
- Page 70 and 71: Federation. The Georgian prosecutor
- Page 72 and 73: went to Argilstone Investment and 4
- Page 74 and 75: (10%). 290 Like Lemise, Interplast
- Page 76 and 77: then buying it back from that group
- Page 78 and 79: elonged to Kapital Vostok, a Swiss
- Page 80 and 81: a fantasy settlement just south of
- Page 82 and 83: made quite a profit, as Sairme is i
- Page 84 and 85: and the Tbilisi Development Fund, t
- Page 86 and 87: land from the Fund along Aghmashene
- Page 88 and 89: On December 24th, the economy minis
- Page 90 and 91: had never been properly notified. 3
- Page 92 and 93: In 2009, Stanton was renamed GeoPro
- Page 94 and 95: Tkibuli is a derelict post-Soviet i
- Page 96 and 97: POSTSCRIPTWhen Georgians went to th
- Page 98 and 99: While Rustavi 2 was passing through
- Page 100 and 101: On October 5, Maestro TV and Global
- Page 102: and further reasons why foreign inv
People’s Pharmacy, a small pharmaceutical chain, complains thatit is impossible to stock as much as he needs without having todeal with the three importers. 230 With the three major companiescontrolling most of the imported medical products, many suspectthey have collaborated to fixed the prices.Studio Monitor mentions this in an investigative report on<strong>Georgia</strong>’s pharmaceutical companies. “The three main players(PSP, Aversi, GPC) on the <strong>Georgia</strong>n pharmaceutical market havean agreement between each other to cooperate with differentsuppliers. If one of them works with Richter, the other two donot meddle. If you tell Richter you’re a new organization andyou want to cooperate with them, they tell you, “I already have apartner in <strong>Georgia</strong> and don’t need another.” 231Kvaratskhelia explains, “It’s like this: one company importsdrugs X and another imports drugs Y and they share these drugstogether. They managed to create an oligopoly by sharing theimport between their companies and sell the shared importeddrugs to pharmacies at a fixed price. Being the major importersand having exclusive contracts with manufacturers, they acquireda position in which pharmacies have become dependent on theirsupply. No other importer is able to sign a contract with them(the manufacturers). Through this control of the import marketand the sharing of exclusive pharmaceuticals, every pharmacy isdependent on them, if it wants to sell foreign drugs.” 232230 Interview Valeri Kvaratskhelia General Director People’s Pharmacy, andrespondent who prefers to stay anonymous. Report on PharmaceuticalMarket in <strong>Georgia</strong>. Pages 14-15 Transparency International <strong>Georgia</strong>http://transparency.ge/sites/default/files/post_attachments/The%20Pharmaceutical%20Market%20in%20<strong>Georgia</strong>_June%202012l_0.<strong>pdf</strong> Accessed05/12/2012231 Darkside of the <strong>Georgia</strong>n Pharmacy. Studio Monitor report. 2009 http://ick.ge/ka/jinvestigation/322-2010-02-17-09-21-51.html Accessed 05/12/2012232 Interview Valeri Kvaratskhelia General Director People’s Pharmacy, andrespondent who prefers to stay anonymous. Report on Pharmaceutical Marketin <strong>Georgia</strong>. Transparency International <strong>Georgia</strong> http://transparency.ge/sites/default/files/post_attachments/The%20Pharmaceutical%20Market%20in%20<strong>Georgia</strong>_June%202012l_0.<strong>pdf</strong> Accessed 05/12/201256
Change language